Inflammation and DNA methylation in Alzheimer’s disease: mechanisms of epigenetic remodelling by immune cell oxidants in the ageing brain

8Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Alzheimer’s disease is a neurodegenerative disease involving memory impairment, confusion, and behavioural changes. The disease is characterised by the accumulation of amyloid beta plaques and neurofibrillary tangles in the brain, which disrupt normal neuronal function. There is no known cure for Alzheimer’s disease and due to increasing life expectancy, occurrence is projected to rise over the coming decades. The causes of Alzheimer’s disease are multifactorial with inflammation, oxidative stress, genetic and epigenetic variation, and cerebrovascular abnormalities among the strongest contributors. We review the current literature surrounding inflammation and epigenetics in Alzheimer’s disease, with a focus on how oxidants from infiltrating immune cells have the potential to alter DNA methylation profiles in the ageing brain.

Cite

CITATION STYLE

APA

Seddon, A. R., MacArthur, C. P., Hampton, M. B., & Stevens, A. J. (2024). Inflammation and DNA methylation in Alzheimer’s disease: mechanisms of epigenetic remodelling by immune cell oxidants in the ageing brain. Redox Report. Taylor and Francis Ltd. https://doi.org/10.1080/13510002.2024.2428152

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free